Lupin Ltd. Sees Significant Open Interest Surge Amidst Mixed Market Signals

1 hour ago
share
Share Via
Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 12.3% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this increase, the stock underperformed its sector and broader indices, reflecting a complex interplay of market sentiment and technical factors.
Lupin Ltd. Sees Significant Open Interest Surge Amidst Mixed Market Signals

Open Interest and Volume Dynamics

The latest data reveals Lupin’s open interest rising from 29,199 contracts to 32,791, an addition of 3,592 contracts, marking a robust 12.3% increase. This surge in OI is accompanied by a futures trading volume of 24,509 contracts, indicating active participation in the derivatives market. The combined futures and options value stands at approximately ₹29,182 lakhs, with futures contributing ₹26,312 lakhs and options an overwhelming ₹20,519.75 crores, underscoring the significant notional exposure in Lupin’s derivatives.

Underlying the derivatives activity, Lupin’s spot price closed at ₹2,165, trading within a narrow intraday range of just ₹0.3, suggesting limited price movement despite the elevated derivatives interest. This divergence between price stability and rising open interest often points to strategic positioning by institutional players, possibly anticipating a directional move or hedging existing exposures.

Market Performance and Technical Indicators

On 27 Aug 2026, Lupin’s stock price declined by 0.90%, underperforming its sector which gained 0.68%, and the Sensex which fell marginally by 0.24%. The stock’s performance today was weaker by 1.39% relative to its sector, signalling relative weakness amid broader market resilience. Technical analysis reveals Lupin trading below all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – indicating a bearish trend across multiple timeframes.

However, investor participation has risen sharply, with delivery volumes on 26 Aug reaching 7.53 lakh shares, a 79.19% increase over the five-day average. This spike in delivery volume suggests that despite the price softness, investors are accumulating shares, possibly in anticipation of a turnaround or as a hedge against derivatives positions.

Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!

  • - Highest rated stock selection
  • - Multi-parameter screening cleared
  • - Large Cap quality pick

View Our Top 1% Pick →

Interpreting the Open Interest Surge

The 12.3% increase in open interest, coupled with steady volume, suggests fresh positions are being established rather than existing ones being squared off. This typically indicates growing conviction among traders about future price movement. Given Lupin’s current downtrend and trading below all major moving averages, the surge in OI could reflect directional bets on further downside or protective hedging by longs.

Alternatively, the narrow price range and rising delivery volumes hint at accumulation, which may signal that some investors are positioning for a potential rebound. The mixed signals from price action and derivatives activity highlight the nuanced market sentiment surrounding Lupin, where cautious optimism coexists with technical weakness.

Mojo Score and Analyst Ratings

Lupin currently holds a Mojo Score of 58.0, placing it in the ‘Hold’ category, a downgrade from its previous ‘Buy’ rating as of 14 Aug 2026. This adjustment reflects a tempered outlook amid recent price underperformance and technical deterioration. The mid-cap pharmaceutical company, with a market capitalisation of approximately ₹98,854 crores, remains a significant player in its sector but faces headwinds that have moderated analyst enthusiasm.

Investors should weigh the stock’s fundamental strengths against the technical challenges and evolving market positioning evident in the derivatives market. The sector’s overall resilience and Lupin’s rising delivery volumes provide some support, but the downward momentum and cautious grading advise prudence.

Considering Lupin Ltd.? Wait! SwitchER has found potentially better options in Pharmaceuticals & Biotechnology and beyond. Compare this mid-cap with top-rated alternatives now!

  • - Better options discovered
  • - Pharmaceuticals & Biotechnology + beyond scope
  • - Top-rated alternatives ready

Compare & Switch Now →

Liquidity and Trading Considerations

Lupin’s liquidity remains adequate for sizeable trades, with the stock’s average traded value supporting a trade size of approximately ₹3.36 crores based on 2% of the five-day average. This level of liquidity is favourable for institutional investors and active traders seeking to enter or exit positions without significant market impact.

Given the current market environment, investors should monitor Lupin’s open interest trends closely, as sustained increases in OI alongside price movements could provide clearer directional cues. The interplay between futures and options volumes, particularly the substantial options notional value, also warrants attention for potential volatility spikes or strategic option plays.

Outlook and Strategic Implications

In summary, Lupin Ltd.’s recent surge in open interest amid subdued price action and technical weakness paints a complex picture. The derivatives market activity suggests that traders are actively repositioning, possibly anticipating a directional move or hedging existing exposures. Meanwhile, rising delivery volumes indicate growing investor interest at the stock level, which could underpin a future recovery.

Investors should adopt a balanced approach, considering both the technical signals and fundamental outlook. The current ‘Hold’ Mojo Grade reflects this cautious stance, recommending that market participants stay alert to evolving price and volume patterns before committing to significant directional bets.

Key Metrics at a Glance:

  • Open Interest: 32,791 contracts (up 12.3%)
  • Futures Volume: 24,509 contracts
  • Futures Value: ₹26,312 lakhs
  • Options Notional Value: ₹20,519.75 crores
  • Stock Price: ₹2,165 (narrow range of ₹0.3)
  • Delivery Volume (26 Aug): 7.53 lakh shares (+79.19%)
  • Mojo Score: 58.0 (Hold, downgraded from Buy on 14 Aug 2026)
  • Market Cap: ₹98,854 crores (Mid Cap)

As Lupin navigates this phase of heightened derivatives activity and technical pressure, investors and traders alike should remain vigilant, leveraging comprehensive data analysis to inform their strategies in this dynamic pharmaceutical sector stock.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News